View Press Releases
-
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones
PARIS, FRANCE - Feb 11, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS-Holdings, alongside the participation of existing investors Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Funds, BNP Paribas Développement and Idinvest Partners
Feb 12, 2020
-
Signant Health Unveils its full Conference Line-up for SCOPE 2020
PHILADELPHIA, PA, UNITED STATES - Feb 11, 2020 - The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyond
Feb 11, 2020
-
Olaris Announces Grant from The Michael J. Fox Foundation for Parkinson’s Research
WALTHAM, MA, UNITED STATES - Feb 11, 2020 - Olaris, a precision medicine company that is fundamentally changing how diseases are diagnosed and treated, today announced it has received a grant from The Michael J
Feb 10, 2020
-
Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film
WARREN, NJ - Feb 10, 2020 - Aquestive Therapeutics, Inc. (AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems, announced today that, as anticipated, the U
Feb 10, 2020
-
Efficient digital documentation of microscopic samples
JENA, GERMANY - Feb 10, 2020 - Smart Microscopy from ZEISS is a new concept for the routine digital documentation of microscopic samples
Feb 10, 2020
-
Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research
PRINCETON, NJ - Feb 10, 2020 - Certara®, the global model-informed drug development and decision support leader, today announced that its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sources
Feb 10, 2020
-
Summit Healthcare to Showcase Robotic Process Automation (RPA) Technology and Services at HIMSS20
BRAINTREE, MA - Feb 6, 2020 - Braintree, Mass., February 6, 2020 - Summit Healthcare, a leading provider of automation and healthcare systems integration technology, today announced that it will be showcasing cutting-edge Robotic Process Automation (RPA) solutions in booth #5558 at the 2020 HIMSS Global Health Conference & Exhibition, which will be held in Orlando, FL, between March 9 and March 13, 2020
Feb 6, 2020
-
Understanding the immune system in Chronic Immune-Mediated inflammatory diseases
GUILDFORD, N/A, UNITED KINGDOM - Feb 5, 2020 - Understanding the immune system inChronic Immune-Mediated inflammatory diseases Our immune system is a complex network of cells and organs that together defend the body against harmful foreign invaders such as bacteria and viruses
Feb 5, 2020
-
Develop high-quality peptidomimetics with Creative Proteomics’ β-Amino Acids Analysis solutions
SHIRLEY, NY, UNITED STATES - Feb 1, 2020 - β-amino acid refers to an amino acid in which an amino group is bonded to a carbon atom at the β position
Feb 4, 2020
-
Accurate and affordable Total RNA sequencing provided by CD Genomics
SHIRLEY, NY, UNITED STATES - Feb 1, 2020 - CD Genomics introduced accurate and affordable RNA-seq and Total RNA sequencing. CD genomics combines proven ribosomal reduction library preparation chemistries and Illumina NGS technology into a single, streamlined protocol, which enable researchers to quickly and easily conduct gene expression studies that provide a complete view of the transcriptome, even from low-quality RNA samples
Feb 4, 2020
-
MR Solutions helps new ImPaKT facility become the best equipped containment laboratory in Canada
GUILDFORD, UNITED KINGDOM - Feb 4, 2020 - MR Solutions has installed a 3T PET-MR preclinical imaging system at Western Universitys one of a kind ImPaKT Laboratory in Ontario
Feb 4, 2020
-
New Elsevier report highlights link between the microbiome and melanoma
NEW YORK, NY, UNITED STATES - Feb 4, 2020 - Elsevier, the information analytics company specializing in science and health, has published the findings of a new report on melanoma R&D, created by its Professional Services group, highlighting the implication of the microbiome in the onset and progression of the disease, as well as in the toxicity of, and response rate, to cancer treatments
Feb 3, 2020
-
Accumen’s 3DR Labs Partners with Resonance Health to Expand its MRI Analysis Services
PHOENIX, AZ - Feb 3, 2020 - Accumen Inc., the leader in healthcare performance, announced today that its 3DR Labs, LLC company is partnering with Resonance Health Limited (ASX: RHT) to provide FerriSmart magnetic resonance imaging- (MRI-) based liver iron concentration reports for its clients
Feb 3, 2020
-
Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites
SLOUGH/DUNDEE, UK - Feb 3, 2020 - Hypha Discovery Limited, the leading specialist CRO for drug metabolite provision, and Cypex Limited, experts in the provision of recombinant xenobiotic metabolising enzymes, have formed a partnership wherein Hypha can scale-up and purify metabolites made by Cypex enzymes (available as Bactosomes)
Feb 3, 2020
-
Greenphire and Lazarex Cancer Foundation Unite to Address Strategies for Improving Patient Access and Retention in Cancer Clinical Trials
KING OF PRUSSIA, PA, UNITED STATES - Jan 31, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)'s annual Global Oncology Site Solutions Summit
Jan 31, 2020
-
Key Biologics Fills Critical Leadership Positions for High-Growth Business
MEMPHIS, TN, UNITED STATES - Jan 30, 2020 - Key Biologics, the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced it has hired two new executives to support its recent growth and ongoing demand for its products and services
Jan 30, 2020
-
Signant Health Enhances Audit Trail Reporting Capabilities in TrialMax® to Improve eCOA Data Integrity Monitoring
PHILADELPHIA, PENNSYLVANIA - Jan 29, 2020 - Signant Health has announced new audit trail reviewing and reporting functionality today for its electronic clinical outcome assessment (eCOA) and remote sensor platform, TrialMax®
Jan 29, 2020
-
Precision Medicine Leaps Ahead with Data Science: Bio-IT World 2020 to Highlight Data-Driven Approaches to Discovery
BOSTON, MA, UNITED STATES - Jan 28, 2020 - Bio-IT World 2020, the leading conference and expo uniting life science, data, informatics and IT leaders, today announced an expanded focus on the Data Science innovations that are moving precision medicine into new frontiers
Jan 28, 2020
-
PHARMASEAL Celebrates A Year of Significant Success as it Prepares for Exciting Program of Industry Conferences in 2020
NOTTINGHAM, UK - Jan 28, 2020 - PHARMASEAL, a new provider of clinical trial management (CTMS) and governance solutions to enter the market, is celebrating a year of significant success, with 2019 marking several important milestones for the company
Jan 28, 2020
-
New Head of KC-based Drug Development CRO poised for further growth and expansion
KANSAS CITY, KS, UNITED STATES - Jan 28, 2020 - Kansas City, KS- SEKISUI XenoTech announces the promotion of Dr. Darren Warren, PhD to President and Chief Executive Officer
Jan 28, 2020